BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24122029)

  • 1. Clinical, immunological, and molecular characterization of hyper-IgM syndrome due to CD40 deficiency in eleven patients.
    Al-Saud BK; Al-Sum Z; Alassiri H; Al-Ghonaium A; Al-Muhsen S; Al-Dhekri H; Arnaout R; Alsmadi O; Borrero E; Abu-Staiteh A; Rawas F; Al-Mousa H; Hawwari A
    J Clin Immunol; 2013 Nov; 33(8):1325-35. PubMed ID: 24122029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and Immunological Features, Genetic Variants, and Outcomes of Patients with CD40 Deficiency.
    Banday AZ; Nisar R; Patra PK; Kaur A; Sadanand R; Chaudhry C; Bukhari STA; Banday SZ; Bhattarai D; Notarangelo LD
    J Clin Immunol; 2023 Dec; 44(1):17. PubMed ID: 38129705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients.
    Winkelstein JA; Marino MC; Ochs H; Fuleihan R; Scholl PR; Geha R; Stiehm ER; Conley ME
    Medicine (Baltimore); 2003 Nov; 82(6):373-84. PubMed ID: 14663287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical spectrum of X-linked hyper-IgM syndrome.
    Levy J; Espanol-Boren T; Thomas C; Fischer A; Tovo P; Bordigoni P; Resnick I; Fasth A; Baer M; Gomez L; Sanders EA; Tabone MD; Plantaz D; Etzioni A; Monafo V; Abinun M; Hammarstrom L; Abrahamsen T; Jones A; Finn A; Klemola T; DeVries E; Sanal O; Peitsch MC; Notarangelo LD
    J Pediatr; 1997 Jul; 131(1 Pt 1):47-54. PubMed ID: 9255191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haematopoietic stem cell transplant for hyper-IgM syndrome due to CD40 defects: a single-centre experience.
    Al-Saud B; Al-Jomaie M; Al-Ghonaium A; Al-Ahmari A; Al-Mousa H; Al-Muhsen S; Al-Seraihy A; Arnaout R; Elshorbagi S; Al-Dhekri H; Ayas M
    Bone Marrow Transplant; 2019 Jan; 54(1):63-67. PubMed ID: 29884852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyper IgM Syndrome: a Report from the USIDNET Registry.
    Leven EA; Maffucci P; Ochs HD; Scholl PR; Buckley RH; Fuleihan RL; Geha RS; Cunningham CK; Bonilla FA; Conley ME; Ferdman RM; Hernandez-Trujillo V; Puck JM; Sullivan K; Secord EA; Ramesh M; Cunningham-Rundles C
    J Clin Immunol; 2016 Jul; 36(5):490-501. PubMed ID: 27189378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory infections in X-linked hyper-IgM syndrome with CD40LG mutation: a case series of seven children in China.
    Fan H; Huang L; Yang D; Zhang C; Zeng Q; Yin G; Lu G; Shen K
    BMC Pediatr; 2022 Nov; 22(1):675. PubMed ID: 36419145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyper-immunoglobulin M syndrome type 3 with normal CD40 cell surface expression.
    Karaca NE; Forveille M; Aksu G; Durandy A; Kutukculer N
    Scand J Immunol; 2012 Jul; 76(1):21-5. PubMed ID: 22443339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different molecular behavior of CD40 mutants causing hyper-IgM syndrome.
    Lanzi G; Ferrari S; Vihinen M; Caraffi S; Kutukculer N; Schiaffonati L; Plebani A; Notarangelo LD; Fra AM; Giliani S
    Blood; 2010 Dec; 116(26):5867-74. PubMed ID: 20702779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and laboratory findings in hyper-IgM syndrome with novel CD40L and AICDA mutations.
    Aghamohammadi A; Parvaneh N; Rezaei N; Moazzami K; Kashef S; Abolhassani H; Imanzadeh A; Mohammadi J; Hammarström L
    J Clin Immunol; 2009 Nov; 29(6):769-76. PubMed ID: 19575287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating Follicular Helper and Follicular Regulatory T Cells Are Severely Compromised in Human CD40 Deficiency: A Case Report.
    Cicalese MP; Gerosa J; Baronio M; Montin D; Licciardi F; Soresina A; Dellepiane RM; Miano M; Baselli LA; Volpi S; Dufour C; Plebani A; Aiuti A; Lougaris V; Fousteri G
    Front Immunol; 2018; 9():1761. PubMed ID: 30131802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pitfalls of "hyper"-IgM syndrome: a new CD40 ligand mutation in the presence of low IgM levels. A case report and a critical review of the literature.
    Heinold A; Hanebeck B; Daniel V; Heyder J; Tran TH; Döhler B; Greil J; Müller FM
    Infection; 2010 Dec; 38(6):491-6. PubMed ID: 20981468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of patients with Hyper-IgM type IV phenotype who recovered spontaneously during late childhood and review of the literature.
    Karaca NE; Durandy A; Gulez N; Aksu G; Kutukculer N
    Eur J Pediatr; 2011 Aug; 170(8):1039-47. PubMed ID: 21274562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperimmunoglobulin syndrome due to CD40 deficiency: possibly the first case from India.
    Mishra A; Italia K; Gupta M; Desai M; Madkaikar M
    J Postgrad Med; 2015; 61(1):46-8. PubMed ID: 25511220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospects for modulating the CD40/CD40L pathway in the therapy of the hyper-IgM syndrome.
    Meng X; Yang B; Suen WC
    Innate Immun; 2018 Jan; 24(1):4-10. PubMed ID: 29132233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and molecular features of X-linked hyper IgM syndrome - An experience from North India.
    Rawat A; Mathew B; Pandiarajan V; Jindal A; Sharma M; Suri D; Gupta A; Goel S; Karim A; Saikia B; Minz RW; Imai K; Nonoyama S; Ohara O; Giliani SC; Notarangelo LD; Chan KW; Lau YL; Singh S
    Clin Immunol; 2018 Oct; 195():59-66. PubMed ID: 30053428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel and recurrent AID mutations underlie prevalent autosomal recessive form of HIGM in consanguineous patients.
    Ouadani H; Ben-Mustapha I; Ben-ali M; Ben-khemis L; Larguèche B; Boussoffara R; Maalej S; Fetni I; Hassayoun S; Mahfoudh A; Mellouli F; Yalaoui S; Masmoudi H; Bejaoui M; Barbouche MR
    Immunogenetics; 2016 Jan; 68(1):19-28. PubMed ID: 26545377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First report of the Hyper-IgM syndrome Registry of the Latin American Society for Immunodeficiencies: novel mutations, unique infections, and outcomes.
    Cabral-Marques O; Klaver S; Schimke LF; Ascendino ÉH; Khan TA; Pereira PV; Falcai A; Vargas-Hernández A; Santos-Argumedo L; Bezrodnik L; Moreira I; Seminario G; Di Giovanni D; Raccio AG; Porras O; Weber CW; Ferreira JF; Tavares FS; de Carvalho E; Valente CF; Kuntze G; Galicchio M; King A; Rosário-Filho NA; Grota MB; dos Santos Vilela MM; Di Gesu RS; Lima S; de Souza Moura L; Talesnik E; Mansour E; Roxo-Junior P; Aldave JC; Goudouris E; Pinto-Mariz F; Berrón-Ruiz L; Staines-Boone T; Calderón WO; del Carmen Zarate-Hernández M; Grumach AS; Sorensen R; Durandy A; Torgerson TR; Carvalho BT; Espinosa-Rosales F; Ochs HD; Condino-Neto A
    J Clin Immunol; 2014 Feb; 34(2):146-56. PubMed ID: 24402618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and Immunological Characterization of Combined Immunodeficiency Due to TFRC Mutation in Eight Patients.
    Aljohani AH; Al-Mousa H; Arnaout R; Al-Dhekri H; Mohammed R; Alsum Z; Nicolas-Jilwan M; Alrogi F; Al-Muhsen S; Alazami AM; Al-Saud B
    J Clin Immunol; 2020 Nov; 40(8):1103-1110. PubMed ID: 32851577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hyper IgM syndromes.
    Qamar N; Fuleihan RL
    Clin Rev Allergy Immunol; 2014 Apr; 46(2):120-30. PubMed ID: 23797640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.